New treatments for deadly snake bites, and a fusion company that wants to get in the medical isotopes game
First up this week, Staff Writer Adrian Cho talks with host Sarah Crespi about a fusion company that isn’t aiming for net energy. Instead, it’s looking to sell off the high-energy neutrons from its fusion reactors for different purposes, such as imaging machine parts and generating medical isotopes. In the long run, the company hopes to use money from these neutron-based enterprises for bigger, more energetic reactors that may someday make fusion energy.
Next, we hear from Tian Du, a Ph.D. candidate in the Dr John and Anne Chong Lab for Functional Genomics at the University of Sydney. She talks about finding antivenom treatments by screening all the genes in the human genome. Her Science Translational Medicine paper focuses on a strong candidate for treating spitting cobra bites, but the technique may prove useful for many other venomous animal bites and stings, from jellyfish to spiders.
This week’s episode was produced with help from Podigy.
Authors: Sarah Crespi, Adrian Cho
Learn more about your ad choices. Visit megaphone.fm/adchoices